Novartis announces pricing for Gilenya oral MS drug

Novartis announced that its new multiple sclerosis drug, Gilenya, will have a wholesale price of about $48 000 a year per person in the US, making it among the most expensive drugs for the condition.
Reference Articles
Novartis MS pill to cost $48,000 on avg per year - (FinanzNachrichten)
Novartis unveils MS drug pricing - (The Wall Street Journal)

**Published in "First Word"